デフォルト表紙
市場調査レポート
商品コード
1386254

女性の健康疾患診断および治療市場レポート:2030年までの動向、予測、競合分析

Women Health Disease Diagnosis & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

女性の健康疾患診断および治療市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

女性の健康疾患診断および治療の動向と予測

世界の女性の健康疾患診断および治療市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定281億9,000万米ドルに達すると予測されます。この市場の主な促進要因は、女性健康障害の増加、女性ヘルスケアに関する意識の高まり、ポイントオブケア検査や迅速診断検査の採用増加です。世界の女性の健康疾患診断および治療市場の将来は、病院、診療所、診断センター市場でのビジネスチャンスにより有望視されています。

女性の健康疾患診断および治療市場の洞察

Lucintelの予測では、予測期間中、がんが最も高い成長を遂げる見込みです。

この市場において、病院は引き続き最大のセグメントです。

アジア太平洋は、ヘルスケアインフラの継続的な改善、女性の健康障害に対する意識の高まり、同地域におけるPOC診断の採用増加により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の女性の健康疾患診断および治療市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の女性の健康疾患の診断と治療市場の動向(2018-2023)と予測(2024-2030)
  • タイプ別の世界の女性の健康疾患診断および治療市場
    • 尿路感染症とその状態
    • 出生前の生殖に関する健康
    • 閉経
    • がん
    • 骨粗鬆症
  • 最終用途別の世界の女性の健康疾患診断および治療市場
    • 病院
    • クリニック
    • 診断センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の女性の健康疾患診断および治療市場
  • 北米の女性の健康疾患診断および治療市場
  • 欧州の女性の健康疾患診断および治療市場
  • アジア太平洋地域の女性の健康疾患診断および治療市場
  • その他地域の女性の健康疾患診断および治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の女性の健康疾患診断および治療市場の成長機会
    • 最終用途別の世界の女性の健康疾患診断および治療市場の成長機会
    • 地域別の世界の女性の健康疾患診断および治療市場の成長機会
  • 世界の女性の健康疾患診断および治療市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の女性の健康疾患診断および治療市場の能力拡大
    • 世界の女性の健康疾患診断および治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories
目次

Women Health Disease Diagnosis & Treatment Trends and Forecast

The future of the global women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets. The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

A more than 150-page report is developed to help in your business decisions.

Women Health Disease Diagnosis & Treatment by Segment

The study includes a forecast for the global women health disease diagnosis & treatment by type, end use, and region.

Women Health Disease Diagnosis & Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Urinary Tract Infection and Condition
  • Prenatal Reproductive Health
  • Menopause
  • Cancer
  • Osteoporosis

Women Health Disease Diagnosis & Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Women Health Disease Diagnosis & Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Women Health Disease Diagnosis & Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies women health disease diagnosis & treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the women health disease diagnosis & treatment companies profiled in this report include-

  • General Electric
  • Coopersurgical
  • Ascend Therapeutics
  • Rinovum Women'S Health
  • Quest Diagnostics Incorporated
  • Hologic
  • Perkinelmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Women Health Disease Diagnosis & Treatment Market Insights

Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Within this market, hospitals will remain the largest segment.

APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Features of the Global Women Health Disease Diagnosis & Treatment Market

Market Size Estimates: Women Health Disease Diagnosis & Treatment Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Women Health Disease Diagnosis & Treatment Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Women Health Disease Diagnosis & Treatment Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the women health disease diagnosis & treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the women health disease diagnosis & treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the women health disease diagnosis & treatment market size?

Answer: The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030.

Q.2 What is the growth forecast for women health disease diagnosis & treatment market?

Answer: The global women health disease diagnosis & treatment market is expected to grow with a cagr of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the women health disease diagnosis & treatment market?

Answer: The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

Q4. What are the major segments for women health disease diagnosis & treatment market?

Answer: The future of the women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets.

Q5. Who are the key women health disease diagnosis & treatment market companies?

Answer: Some of the key women health disease diagnosis & treatment companies are as follows:

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Q6. Which women health disease diagnosis & treatment market segment will be the largest in future?

Answer: Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Q7. In women health disease diagnosis & treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the women health disease diagnosis & treatment market by type (urinary tract infection and condition, prenatal reproductive health, menopause, cancer, and osteoporosis), end use (hospitals, clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Women Health Disease Diagnosis & Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Women Health Disease Diagnosis & Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Women Health Disease Diagnosis & Treatment Market by Type
    • 3.3.1: Urinary Tract Infection and Condition
    • 3.3.2: Prenatal Reproductive Health
    • 3.3.3: Menopause
    • 3.3.4: Cancer
    • 3.3.5: Osteoporosis
  • 3.4: Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Clinics
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Women Health Disease Diagnosis & Treatment Market by Region
  • 4.2: North American Women Health Disease Diagnosis & Treatment Market
    • 4.2.2: North American Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.3: European Women Health Disease Diagnosis & Treatment Market
    • 4.3.1: European Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.3.2: European Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Women Health Disease Diagnosis & Treatment Market
    • 4.4.1: APAC Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.4.2: APAC Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Women Health Disease Diagnosis & Treatment Market
    • 4.5.1: ROW Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.5.2: ROW Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 6.1.3: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Region
  • 6.2: Emerging Trends in the Global Women Health Disease Diagnosis & Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: CooperSurgical
  • 7.3: ASCEND Therapeutics
  • 7.4: Rinovum Women's Health
  • 7.5: Quest Diagnostics Incorporated
  • 7.6: Hologic
  • 7.7: PerkinElmer
  • 7.8: Cardinal Health
  • 7.9: Becton and Dickinson
  • 7.10: Abbott Laboratories